Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA clears Mobius glaucoma drug
Mitosol delivers a precise dose of its active ingredient, mitomycin-c, providing ophthalmic surgeons for use in procedures without any change to their current technique. In collaboration with St
Mitosol delivers a precise dose of its active ingredient, mitomycin-c, providing ophthalmic surgeons for use in procedures without any change to their current technique. In collaboration with St
As a part of the expanded contract, StayinFront will offer extended hours of technical support across a range of applications for their home office colleagues. StayinFront’s technical staff
The trial data showed that cariprazine treated patients with acute manic episodes experienced significant improvements in symptoms compared to placebo-treated patients. The results of this study were consistent
The novel anti-cancer molecule is expected to go into clinical trials by 2012 and both the companies will continue the collaboration in the development phase as well. Endo
Takeda Pharmaceutical (China) Company in Taizhou is responsible for marketing and sales, and Tianjin Takeda Pharmaceuticals in Tianjin is responsible for manufacturing. Together with Takeda China and Tianjin
As per the agreement, Zalicus will pay Hydra an upfront payment and fund research and development activities at Hydra for a two-year period. Hydra will perform the preclinical
Doxycycline Hyclate DR tablets are the generic version of the company’s Doryx, which is marketed by Warner Chilcott. Mylan CEO Heather Bresch said they are pleased by FDA’s
As per the settlement agreement, the companies have signed a supply agreement whereby Janssen will manufacture and supply Watson with an authorized generic version of ORTHO TRI-CYCLEN LO.
Through the collaboration, the newly launched MRF Translational Medicine Center will determine the myelin regenerating capabilities of proprietary small molecule compounds from Endece Neural. The aim of the
Brachyury is over-expressed in a variety of important tumor types including breast, colon, lung and prostate cancers. The primary endpoint of open-label study is the safety and tolerability